3-(2,2,2-trimethylhydrazine)propionate has been researched along with Metabolic Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blank, C; Dünnwald, T; Gmeiner, G; Schobersberger, W | 1 |
1 review(s) available for 3-(2,2,2-trimethylhydrazine)propionate and Metabolic Diseases
| Article | Year |
|---|---|
Story behind meldonium-from pharmacology to performance enhancement: a narrative review.
Topics: Athletes; Athletic Performance; Cardiovascular Diseases; Carnitine; Doping in Sports; Humans; Metabolic Diseases; Methylhydrazines; Nervous System Diseases | 2017 |